FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

377460002: Product containing precisely hydralazine hydrochloride 25 milligram and hydrochlorothiazide 15 milligram and reserpine 100 microgram/1 each conventional release oral tablet (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3699880012 Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3699881011 Product containing precisely hydralazine hydrochloride 25 milligram and hydrochlorothiazide 15 milligram and reserpine 100 microgram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet est un(e) (attribut) Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form true Inferred relationship Some
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet Plays role Diuretic therapeutic role true Inferred relationship Some
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet Has precise active ingredient chlorhydrate d'hydralazine (substance) true Inferred relationship Some 1
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet Has precise active ingredient Reserpine (substance) true Inferred relationship Some 2
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet Has presentation strength numerator unit microgram (qualifier value) true Inferred relationship Some 2
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet est un(e) (attribut) Product containing hydrochlorothiazide (medicinal product) false Inferred relationship Some
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet est un(e) (attribut) Product containing hydralazine (medicinal product) false Inferred relationship Some
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet a pour principe actif (attribut) Hydralazine (substance) false Inferred relationship Some
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet a pour principe actif (attribut) Hydrochlorothiazide (substance) false Inferred relationship Some
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet est un(e) (attribut) Hydralazine hydrochloride + hydrochlorothiazide + reserpine false Inferred relationship Some
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet a pour principe actif (attribut) chlorhydrate d'hydralazine (substance) false Inferred relationship Some
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet a pour principe actif (attribut) Centrally acting hypotensive agent (substance) false Inferred relationship Some
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet a pour principe actif (attribut) Reserpine (substance) false Inferred relationship Some
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet a une forme pharmaceutique (attribut) comprimé false Inferred relationship Some
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet a une forme pharmaceutique (attribut) Oral tablet true Inferred relationship Some
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet est un(e) (attribut) Hydralazine-containing product in oral dose form false Inferred relationship Some
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet est un(e) (attribut) Hydrochlorothiazide-containing product in oral dose form false Inferred relationship Some
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet Has presentation strength numerator unit milligram (qualifier value) true Inferred relationship Some 1
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet Has presentation strength denominator value un false Inferred relationship Some 1
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 1
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet a pour principe actif (attribut) Reserpine (substance) false Inferred relationship Some 2
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet Has basis of strength substance (attribute) Reserpine (substance) true Inferred relationship Some 2
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet Has presentation strength numerator value (attribute) 0.1 (qualifier value) false Inferred relationship Some 2
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet Has presentation strength numerator unit milligram (qualifier value) false Inferred relationship Some 2
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet Has presentation strength denominator value un false Inferred relationship Some 2
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 2
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet Has presentation strength numerator unit milligram (qualifier value) true Inferred relationship Some 3
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet Has presentation strength denominator value un false Inferred relationship Some 3
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 3
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet a pour principe actif (attribut) chlorhydrate d'hydralazine (substance) false Inferred relationship Some 1
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet Has basis of strength substance (attribute) chlorhydrate d'hydralazine (substance) true Inferred relationship Some 1
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet Has presentation strength numerator value (attribute) 25 (qualifier value) false Inferred relationship Some 1
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet Has basis of strength substance (attribute) Reserpine (substance) false Inferred relationship Some 1
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet Has basis of strength substance (attribute) chlorhydrate d'hydralazine (substance) false Inferred relationship Some 2
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet Has presentation strength numerator value (attribute) 25 (qualifier value) false Inferred relationship Some 2
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet a pour principe actif (attribut) Hydrochlorothiazide (substance) false Inferred relationship Some 3
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet Has basis of strength substance (attribute) Hydrochlorothiazide (substance) true Inferred relationship Some 3
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet Has presentation strength numerator value (attribute) 15 (qualifier value) false Inferred relationship Some 3
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet est un(e) (attribut) Product containing hydrochlorothiazide and reserpine (medicinal product) false Inferred relationship Some
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet Has precise active ingredient chlorhydrate d'hydralazine (substance) false Inferred relationship Some 2
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet Has unit of presentation Tablet (unit of presentation) true Inferred relationship Some
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet est un(e) (attribut) Product containing rauwolfia alkaloid in oral dose form (medicinal product form) false Inferred relationship Some
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet Has precise active ingredient Hydrochlorothiazide (substance) true Inferred relationship Some 3
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet Has precise active ingredient Reserpine (substance) false Inferred relationship Some 1
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet est un(e) (attribut) Hydralazine- and hydrochlorothiazide-containing product in oral dose form false Inferred relationship Some
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet Count of base of active ingredient trois false Inferred relationship Some
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet Has presentation strength numerator value (attribute) 100 false Inferred relationship Some 1
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet Has presentation strength numerator unit microgram (qualifier value) false Inferred relationship Some 1

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

Canada English language reference set (foundation metadata concept)

GB English

US English

Back to Start